Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population

Authors: Gini GC van Rijckevorsel, Marjolein Damen, Gerard J Sonder, Maarten F Schim van der Loeff, Anneke van den Hoek

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

In the Netherlands, infection with varicella-zoster virus (VZV) is considered a benign common childhood illness and routine vaccination against VZV is not done. In 1995 it was estimated that 98-100% of the adult Dutch general population is immune, yet the estimate is based on a database in which a relative small number of people of non-Dutch ethnic origin were represented. As the city of Amsterdam has large immigrant communities originating from various subtropical and tropical countries, such as Morocco, Surinam, and Turkey with probably lower VZV transmission, this study aimed to estimate the seroprevalence of VZV IgG antibodies (anti-VZV) among various ethnic groups in Amsterdam, and identify factors associated with seronegative VZV status.

Methods

The study was a cross-sectional survey of the Amsterdam population (2004), and the study sample was stratified by age and ethnicity, with deliberate oversampling of minority ethnic groups. Serum samples obtained from 1,341 residents in 2004 were tested for antibodies to VZV. Basic demographic data (gender, age, country of birth, age at immigration and number of children) were also available.

Results

The anti-VZV seroprevalence in the overall Amsterdam population was estimated to be 94% (95% confidence intervals; 92–96%). Regarding ethnic origin, first generation immigrants (Moroccan immigrants 90%, Surinamese or Antillean immigrants 91%, and Turkish 92%), especially those that migrated after the age of 11 years, were more likely to be anti-VZV seronegative compared to those arriving at an earlier age or those born in the Netherlands (97–98%). Both ethnic origin and generation of immigration were positive predictors for IgG seronegativity to VZV (p<0.015). No other predictors for seronegativity were found.

Conclusion

The results of this study imply that about 4–8% of the general adult Amsterdam population is still susceptible to infection with VZV, and that susceptibility is even higher in some immigrant groups. When assessing the risk of infection after VZV exposure alertness is needed for vulnerable persons like pregnant women, patients with hematological malignancies or organ transplants in particular among first-generation immigrants.
Literature
3.
go back to reference de Melker HE, Berbers G, Hahne S, Rumke H, van den Hof S, de Wit A, Boot H: The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine. 2006, 24: 3946-3952. 10.1016/j.vaccine.2006.02.017.CrossRefPubMed de Melker HE, Berbers G, Hahne S, Rumke H, van den Hof S, de Wit A, Boot H: The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine. 2006, 24: 3946-3952. 10.1016/j.vaccine.2006.02.017.CrossRefPubMed
4.
go back to reference de Melker HE, Nagelkerde NJ, Conyn-van Spaendonck MA: Non-participation in a population-based seroprevalence study of vaccine-preventable diseases. Epidemiol Infect. 2000, 124: 255-262. 10.1017/S0950268899003234.CrossRefPubMedPubMedCentral de Melker HE, Nagelkerde NJ, Conyn-van Spaendonck MA: Non-participation in a population-based seroprevalence study of vaccine-preventable diseases. Epidemiol Infect. 2000, 124: 255-262. 10.1017/S0950268899003234.CrossRefPubMedPubMedCentral
5.
go back to reference Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, et al: The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007, 25: 7866-7872. 10.1016/j.vaccine.2007.07.036.CrossRefPubMed Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, et al: The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007, 25: 7866-7872. 10.1016/j.vaccine.2007.07.036.CrossRefPubMed
6.
go back to reference Nichols RA, Averbeck KT, Poulsen AG, al Bassam MM, Cabral F, Aaby P, Breuer J: Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity. Epidemics. 2011, 3: 12-18. 10.1016/j.epidem.2010.11.003.CrossRefPubMedPubMedCentral Nichols RA, Averbeck KT, Poulsen AG, al Bassam MM, Cabral F, Aaby P, Breuer J: Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity. Epidemics. 2011, 3: 12-18. 10.1016/j.epidem.2010.11.003.CrossRefPubMedPubMedCentral
7.
go back to reference Rice PS: Ultra-violet radiation is responsible for the differences in global epidemiology of chickenpox and the evolution of varicella-zoster virus as man migrated out of Africa. Virol J. 2011, 8: 189-10.1186/1743-422X-8-189.CrossRefPubMedPubMedCentral Rice PS: Ultra-violet radiation is responsible for the differences in global epidemiology of chickenpox and the evolution of varicella-zoster virus as man migrated out of Africa. Virol J. 2011, 8: 189-10.1186/1743-422X-8-189.CrossRefPubMedPubMedCentral
8.
go back to reference Agyemang C, Ujcic-Voortman J, Uitenbroek D, Foets M, Droomers M: Prevalence and management of hypertension among Turkish, Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: The Amsterdam Health Monitor Survey. J Hypertens. 2006, 24: 2169-2176. 10.1097/01.hjh.0000249693.73618.c9.CrossRefPubMed Agyemang C, Ujcic-Voortman J, Uitenbroek D, Foets M, Droomers M: Prevalence and management of hypertension among Turkish, Moroccan and native Dutch ethnic groups in Amsterdam, the Netherlands: The Amsterdam Health Monitor Survey. J Hypertens. 2006, 24: 2169-2176. 10.1097/01.hjh.0000249693.73618.c9.CrossRefPubMed
10.
go back to reference Breuer J, Schmid DS, Gershon AA: Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella. J Infect Dis. 2008, 197 (Suppl 2): S147-S151.CrossRefPubMed Breuer J, Schmid DS, Gershon AA: Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella. J Infect Dis. 2008, 197 (Suppl 2): S147-S151.CrossRefPubMed
11.
go back to reference Baaten GG, Sonder GJ, Dukers NH, Coutinho RA, Van den Hoek JA: Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004. J Med Virol. 2007, 79: 1802-1810. 10.1002/jmv.21009.CrossRefPubMed Baaten GG, Sonder GJ, Dukers NH, Coutinho RA, Van den Hoek JA: Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004. J Med Virol. 2007, 79: 1802-1810. 10.1002/jmv.21009.CrossRefPubMed
12.
go back to reference Fassaert T, de Wit MA, Verhoeff AP, Tuinebreijer WC, Gorissen WH, Beekman AT, Dekker J: Uptake of health services for common mental disorders by first-generation Turkish and Moroccan migrants in the Netherlands. BMC Public Health. 2009, 9: 307-10.1186/1471-2458-9-307.CrossRefPubMedPubMedCentral Fassaert T, de Wit MA, Verhoeff AP, Tuinebreijer WC, Gorissen WH, Beekman AT, Dekker J: Uptake of health services for common mental disorders by first-generation Turkish and Moroccan migrants in the Netherlands. BMC Public Health. 2009, 9: 307-10.1186/1471-2458-9-307.CrossRefPubMedPubMedCentral
13.
go back to reference Heininger U, Braun-Fahrlander C, Desgrandchamps D, Glaus J, Grize L, Wutzler P, Schaad UB: Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. Pediatr Infect Dis J. 2001, 20: 775-778. 10.1097/00006454-200108000-00011.CrossRefPubMed Heininger U, Braun-Fahrlander C, Desgrandchamps D, Glaus J, Grize L, Wutzler P, Schaad UB: Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. Pediatr Infect Dis J. 2001, 20: 775-778. 10.1097/00006454-200108000-00011.CrossRefPubMed
14.
go back to reference Khoshnood B, Debruyne M, Lancon F, Emery C, Fagnani F, Durand I, Floret D: Seroprevalence of varicella in the French population. Pediatr Infect Dis J. 2006, 25: 41-44. 10.1097/01.inf.0000195636.43584.bb.CrossRefPubMed Khoshnood B, Debruyne M, Lancon F, Emery C, Fagnani F, Durand I, Floret D: Seroprevalence of varicella in the French population. Pediatr Infect Dis J. 2006, 25: 41-44. 10.1097/01.inf.0000195636.43584.bb.CrossRefPubMed
15.
go back to reference Mossong J, Putz L, Schneider F: Seroprevalence and force of infection of varicella-zoster virus in Luxembourg. Epidemiol Infect. 2004, 132: 1121-1127. 10.1017/S0950268804002754.CrossRefPubMedPubMedCentral Mossong J, Putz L, Schneider F: Seroprevalence and force of infection of varicella-zoster virus in Luxembourg. Epidemiol Infect. 2004, 132: 1121-1127. 10.1017/S0950268804002754.CrossRefPubMedPubMedCentral
16.
go back to reference Salleras L, Dominguez A, Vidal J, Plans P, Salleras M, Taberner JL: Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine. 2000, 19: 183-188. 10.1016/S0264-410X(00)00178-X.CrossRefPubMed Salleras L, Dominguez A, Vidal J, Plans P, Salleras M, Taberner JL: Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes. Vaccine. 2000, 19: 183-188. 10.1016/S0264-410X(00)00178-X.CrossRefPubMed
17.
go back to reference Thiry N, Beutels P, Shkedy Z, Vranckx R, Vandermeulen C, Wielen MV, Damme PV: The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium). Eur J Pediatr. 2002, 161: 588-593. 10.1007/s00431-002-1053-2.CrossRefPubMed Thiry N, Beutels P, Shkedy Z, Vranckx R, Vandermeulen C, Wielen MV, Damme PV: The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium). Eur J Pediatr. 2002, 161: 588-593. 10.1007/s00431-002-1053-2.CrossRefPubMed
18.
go back to reference Vyse AJ, Gay NJ, Hesketh LM, Morgan-Capner P, Miller E: Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect. 2004, 132: 1129-1134. 10.1017/S0950268804003140.CrossRefPubMedPubMedCentral Vyse AJ, Gay NJ, Hesketh LM, Morgan-Capner P, Miller E: Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect. 2004, 132: 1129-1134. 10.1017/S0950268804003140.CrossRefPubMedPubMedCentral
19.
go back to reference Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A: Seroprevalence of varicella-zoster virus in the German population. Vaccine. 2001, 20: 121-124. 10.1016/S0264-410X(01)00276-6.CrossRefPubMed Wutzler P, Farber I, Wagenpfeil S, Bisanz H, Tischer A: Seroprevalence of varicella-zoster virus in the German population. Vaccine. 2001, 20: 121-124. 10.1016/S0264-410X(01)00276-6.CrossRefPubMed
20.
go back to reference Liyanage NP, Fernando S, Malavige GN, Mallikahewa R, Sivayogan S, Jiffry MT, Vitarana T: Seroprevalence of varicella zoster virus infections in Colombo district, Sri Lanka. Indian J Med Sci. 2007, 61: 128-134. 10.4103/0019-5359.30747.CrossRefPubMed Liyanage NP, Fernando S, Malavige GN, Mallikahewa R, Sivayogan S, Jiffry MT, Vitarana T: Seroprevalence of varicella zoster virus infections in Colombo district, Sri Lanka. Indian J Med Sci. 2007, 61: 128-134. 10.4103/0019-5359.30747.CrossRefPubMed
21.
go back to reference Mandal BK, Mukherjee PP, Murphy C, Mukherjee R, Naik T: Adult susceptibility to varicella in the tropics is a rural phenomenon due to the lack of previous exposure. J Infect Dis. 1998, 178 (Suppl 1): S52-S54.CrossRefPubMed Mandal BK, Mukherjee PP, Murphy C, Mukherjee R, Naik T: Adult susceptibility to varicella in the tropics is a rural phenomenon due to the lack of previous exposure. J Infect Dis. 1998, 178 (Suppl 1): S52-S54.CrossRefPubMed
22.
go back to reference Knowles SJ, Grundy K, Cahill I, Cafferkey MT: Susceptibility to infectious rash illness in pregnant women from diverse geographical regions. Commun Dis Public Health. 2004, 7: 344-348.PubMed Knowles SJ, Grundy K, Cahill I, Cafferkey MT: Susceptibility to infectious rash illness in pregnant women from diverse geographical regions. Commun Dis Public Health. 2004, 7: 344-348.PubMed
23.
go back to reference Huisman J: An outbreak of varicella among a group of West Indians residing in the Netherlands. Ned Tijdschr Geneeskd. 1966, 110: 2099-2101.PubMed Huisman J: An outbreak of varicella among a group of West Indians residing in the Netherlands. Ned Tijdschr Geneeskd. 1966, 110: 2099-2101.PubMed
24.
go back to reference Barnett ED, Christiansen D, Figueira M: Seroprevalence of measles, rubella, and varicella in refugees. Clin Infect Dis. 2002, 35: 403-408. 10.1086/341772.CrossRefPubMed Barnett ED, Christiansen D, Figueira M: Seroprevalence of measles, rubella, and varicella in refugees. Clin Infect Dis. 2002, 35: 403-408. 10.1086/341772.CrossRefPubMed
25.
go back to reference Gabutti G, Fedele A, Aprile V, Guido M, Lopalco P: Immigration flows and new epidemiological evidence in southern Italy. Vaccine. 2003, 21: 399-400. 10.1016/S0264-410X(02)00402-4.CrossRefPubMed Gabutti G, Fedele A, Aprile V, Guido M, Lopalco P: Immigration flows and new epidemiological evidence in southern Italy. Vaccine. 2003, 21: 399-400. 10.1016/S0264-410X(02)00402-4.CrossRefPubMed
26.
go back to reference Kjersem H, Jepsen S: Varicella among immigrants from the tropics, a health problem. Scand J Soc Med. 1990, 18: 171-174.PubMed Kjersem H, Jepsen S: Varicella among immigrants from the tropics, a health problem. Scand J Soc Med. 1990, 18: 171-174.PubMed
27.
go back to reference Merrett P, Schwartzman K, Rivest P, Greenaway C: Strategies to prevent varicella among newly arrived adult immigrants and refugees: a cost-effectiveness analysis. Clin Infect Dis. 2007, 44: 1040-1048. 10.1086/512673.CrossRefPubMed Merrett P, Schwartzman K, Rivest P, Greenaway C: Strategies to prevent varicella among newly arrived adult immigrants and refugees: a cost-effectiveness analysis. Clin Infect Dis. 2007, 44: 1040-1048. 10.1086/512673.CrossRefPubMed
28.
go back to reference Cohen DI, Davidovici BB, Smetana Z, Balicer RD, Klement E, Mendelson E, Green MS: Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines. Infection. 2006, 34: 208-213. 10.1007/s15010-006-6604-4.CrossRefPubMed Cohen DI, Davidovici BB, Smetana Z, Balicer RD, Klement E, Mendelson E, Green MS: Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines. Infection. 2006, 34: 208-213. 10.1007/s15010-006-6604-4.CrossRefPubMed
29.
30.
go back to reference Silhol R, Alvarez FP, Arena C, Amoros JP, Flahault A, Hanslik T, Boelle PY: Micro and macro population effects in disease transmission: the case of varicella. Epidemiol Infect. 2010, 138: 482-490. 10.1017/S0950268809990896.CrossRefPubMed Silhol R, Alvarez FP, Arena C, Amoros JP, Flahault A, Hanslik T, Boelle PY: Micro and macro population effects in disease transmission: the case of varicella. Epidemiol Infect. 2010, 138: 482-490. 10.1017/S0950268809990896.CrossRefPubMed
31.
go back to reference van Lier A, van der Maas NA, Rodenburg GD, Sanders EA, de Melker HE: Hospitalization due to varicella in the Netherlands. BMC Infect Dis. 2011, 11: 85-10.1186/1471-2334-11-85.CrossRefPubMedPubMedCentral van Lier A, van der Maas NA, Rodenburg GD, Sanders EA, de Melker HE: Hospitalization due to varicella in the Netherlands. BMC Infect Dis. 2011, 11: 85-10.1186/1471-2334-11-85.CrossRefPubMedPubMedCentral
32.
go back to reference Brisson M, Edmunds WJ, Gay NJ, Law B, De SG: Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000, 125: 651-669. 10.1017/S0950268800004714.CrossRefPubMedPubMedCentral Brisson M, Edmunds WJ, Gay NJ, Law B, De SG: Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000, 125: 651-669. 10.1017/S0950268800004714.CrossRefPubMedPubMedCentral
33.
go back to reference Boot HJ, de Melker HE, Stolk EA, de Wit GA, Kimman TG: Assessing the introduction of universal varicella vaccination in the Netherlands. Vaccine. 2006, 24: 6288-6299. 10.1016/j.vaccine.2006.05.071.CrossRefPubMed Boot HJ, de Melker HE, Stolk EA, de Wit GA, Kimman TG: Assessing the introduction of universal varicella vaccination in the Netherlands. Vaccine. 2006, 24: 6288-6299. 10.1016/j.vaccine.2006.05.071.CrossRefPubMed
34.
go back to reference Brisson M, Edmunds WJ, Gay NJ: Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol. 2003, 70 (Suppl 1): S31-S37.CrossRefPubMed Brisson M, Edmunds WJ, Gay NJ: Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol. 2003, 70 (Suppl 1): S31-S37.CrossRefPubMed
35.
go back to reference Sengupta N, Booy R, Schmitt HJ, Peltola H, Van-Damme P, Schumacher RF, Campins M, Rodrigo C, Heikkinen T, Seward J, et al: Varicella vaccination in Europe: are we ready for a universal childhood programme?. Eur J Pediatr. 2008, 167: 47-55.CrossRefPubMed Sengupta N, Booy R, Schmitt HJ, Peltola H, Van-Damme P, Schumacher RF, Campins M, Rodrigo C, Heikkinen T, Seward J, et al: Varicella vaccination in Europe: are we ready for a universal childhood programme?. Eur J Pediatr. 2008, 167: 47-55.CrossRefPubMed
36.
go back to reference Boelle PY, Hanslik T: Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect. 2002, 129: 599-606. 10.1017/S0950268802007720.CrossRefPubMedPubMedCentral Boelle PY, Hanslik T: Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect. 2002, 129: 599-606. 10.1017/S0950268802007720.CrossRefPubMedPubMedCentral
37.
go back to reference Noorda J, Hoebe CJ: Fatal outbreak of chickenpox (varicella-zoster virus infection) among institutionalised adults with learning difficulties. Commun Dis Public Health. 2004, 7: 164-168.PubMed Noorda J, Hoebe CJ: Fatal outbreak of chickenpox (varicella-zoster virus infection) among institutionalised adults with learning difficulties. Commun Dis Public Health. 2004, 7: 164-168.PubMed
38.
go back to reference Leikin E, Figueroa R, Bertkau A, Lysikiewicz A, Visintainer P, Tejani N: Seronegativity to varicella-zoster virus in a tertiary care obstetric population. Obstet Gynecol. 1997, 90: 511-513. 10.1016/S0029-7844(97)00353-0.CrossRefPubMed Leikin E, Figueroa R, Bertkau A, Lysikiewicz A, Visintainer P, Tejani N: Seronegativity to varicella-zoster virus in a tertiary care obstetric population. Obstet Gynecol. 1997, 90: 511-513. 10.1016/S0029-7844(97)00353-0.CrossRefPubMed
Metadata
Title
Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population
Authors
Gini GC van Rijckevorsel
Marjolein Damen
Gerard J Sonder
Maarten F Schim van der Loeff
Anneke van den Hoek
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-140

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.